Lymphoma
Conditions
Keywords
quality of life, psychosocial intervention, supportive care, cancer survivorship, resilience
Brief summary
The goal of this trial is to learn if a resilience intervention can lead to improvements in lymphoma survivors' quality of life.
Detailed description
The Stress Management and Relaxation Response Resiliency Program for lymphoma survivors (SMART3RP-Lymphoma) was adapted by researchers at the MGH. This group program seeks to buffer stress and promote psychological resiliency and physical well-being through a variety of mind-body approaches, such as imagery, relaxation, and yoga, cognitive behavioral strategies, and positive psychology tools. The main questions it aims to answer are: * Will survivors randomized to SMART3RP-Lymphoma demonstrate greater improvements in quality of life when compared to survivors randomized to a Health Education Program? * Will improvements in resiliency lead to improvements in quality of life? To answer these questions, researchers will compare a resilience intervention tailored to the needs of lymphoma survivors (SMART3RP-Lymphoma) to a Health Education Program to see how they affect quality of life of lymphoma survivors. Participants will: * Fill out 4 surveys across 12 months * Participate in 8 weekly, virtual group sessions * Submit hair cortisol samples
Interventions
8 weekly sessions that include education on the co-occurrence of mental and physical problems, goal setting for health behavior change, and self-monitoring. Each session includes basic didactic information, interactive application of the information, and open discussion of didactic material.
The SMART3RP-lymphoma is a group program that, through a variety of mind-body approaches, such as imagery, relaxation, and yoga, seeks to buffer stress and promote psychological resiliency and physical well-being.
Sponsors
Study design
Eligibility
Inclusion criteria
* English or Spanish speaking adults (18+ at time of enrollment) * Within 2 years of completing active, curative treatment for lymphoma (includes surgery, chemotherapy, immunotherapy, radiation therapy, or other)
Exclusion criteria
* Active psychiatric or cognitive comorbidity as determined by the site PI or treating clinician
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Quality of Life (QoL): Change in PROMIS-29 | From enrollment to 6 month follow up | To examine the effects of the SMART3RP-Lymphoma vs. a Health Education Program (HEP) in improving quality of life in early posttreatment lymphoma survivors. Quality of life will be measured using the PROMIS-29 which assesses physical, functional, emotional, and social quality of life. Each survey item is measured on a 1-5 scale. The unit of measurement is a score on a scale. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Resilience: Change in Scores on the Current Experiences Scale (CES) | Enrollment to 3 month follow up | To compare the effects of the SMART3RP-Lymphoma vs. a Health Education Program (HEP) on resilience in posttreatment lymphoma survivors. Resilience will be measured by the Current Experiences Scale (CES). The CES is a 23-item measure that assesses the following domains of resilience on 0-5 scale: appreciation for life, adaptive perspectives, personal strength, spiritual connectedness, relating to others, and health behaviors. The unit of measurement is a score on a scale. |
Countries
United States